# Yale Drug use, Addiction and HIV Research Scholars (DAHRS)

> **NIH NIH K12** · YALE UNIVERSITY · 2020 · $523,901

## Abstract

7. Project Summary/Abstract
The Yale-Drug use, Addiction and HIV Research Scholar program (DAHRS) began in 2013 with the aim of
training a group of diverse young faculty from multiple medical specialties to meet the critical need to develop a
pool of highly trained clinician scholars to conduct biomedical, behavioral and clinical research related to drug
use, addiction, and HIV prevention and treatment in general medical settings. Patients with substance use
disorders often receive medical care in general medical settings such as primary care clinics and emergency
departments; HIV, adolescent and women's health and other specialty clinics; presenting with a complex array
of acute consequences and complications (e.g. intoxication, overdose, withdrawal, and trauma) of substance
use and chronic conditions such as pain, HIV disease, hepatitis, pulmonary and cardiac disease. Patients are
increasingly presenting to these settings for the prevention and treatment of addiction itself. The Yale-DAHRS
program provides a comprehensive three year post-doctorate, interdisciplinary Mentored Career Development
Program that incorporates a robust didactic research curriculum leading to a Masters in Health Science
degree, mentored research and training in topics related to Addiction Medicine to: [Aim 1] Develop clinician
scientists with the knowledge, skills, and ability to become independent investigators, generating findings of
practical value with significant impact to improve health in patients with and at risk for drug use, addiction, and
HIV; [Aim 2] Develop future leaders by providing Scholars with leadership skills and creating individualized
programs to ensure success in leading multidisciplinary research teams in studying drug use, addiction and
HIV, and implementation and integration of research findings into general medical settings; and [Aim 3]
Enhance the diversity of drug use, addiction, and HIV researchers. Supporting the careers of women and
under-represented minority faculty enhances the diversity of investigators and research topics, broadens
perspectives in setting research priorities, increases clinical trial participation, and expands knowledge. To
date, our program has demonstrated success capitalizing on the synergies of established training and clinical
programs at Yale and our community partners, and the experiences offered by our seasoned, diverse group of
interdisciplinary core faculty, mentors and advisory committee. We have enrolled five Scholars (four women)
from the fields of internal medicine, pediatrics, emergency medicine, obstetrics and gynecology and pulmonary
medicine. All three graduates accepted academic research positions. One has received independent NIDA
R01 funding and is co-investigator on two NIH funded grants; one received PI pilot funding from two
institutional NIH grants and is awaiting an R21 NIH review; the third is a co-investigator on NIDA and CDC
grants and is awaiting review on two grants. All have published i...

## Key facts

- **NIH application ID:** 9969232
- **Project number:** 5K12DA033312-08
- **Recipient organization:** YALE UNIVERSITY
- **Principal Investigator:** Gail D'Onofrio
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $523,901
- **Award type:** 5
- **Project period:** 2013-04-15 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9969232

## Citation

> US National Institutes of Health, RePORTER application 9969232, Yale Drug use, Addiction and HIV Research Scholars (DAHRS) (5K12DA033312-08). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9969232. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*